NASDAQ:OTLK

Outlook Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy OTLK

*Your capital is at risk

$0.81

-0.0038 (-0.467%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

OTLK Prediction Chart

OTLK Predictions History

Latest community submissions for OTLK.

Predictor	Target Session	Target Price	Result	Direction	Accuracy
PumpTheseNumbers Pro	May 28, 2019	$2.65 -95.37%	$2.86	V	92.66%
JS Pro	May 24, 2019	$1.51 -97.29%	$2.79	V	54.12%
joe1234 Pro	May 24, 2019	$2.70 -95.16%	$2.79	X	96.77%
Ataulmusawar.Adnan.Shakil.111381	May 24, 2019	$2.45 -95.61%	$2.79	V	87.81%
Jace.Bloomer.111714	May 24, 2019	$2.51 -95.50%	$2.79	V	89.96%

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OTLK with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT OUTLOOK THERAPEUTICS INC.

Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by